AIM
EXAS

Alambic Investment Management’s Exact Sciences EXAS Stock Holding History

Alambic Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,950
Closed -$317K – 517
2017
Q2 		$317K Buy
+8,950
New +$276K 0.04% 452

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Alambic Investment Management's EXAS Position: Q3 2017 in Review

Alambic Investment Management sold out of Exact Sciences (EXAS) in Q3 2017, closing a stake of 8,950 shares — an estimated $317K sold.

Alambic Investment Management first reported a position in EXAS in Q2 2017 and held it in 1 quarter. The position peaked at $317K in Q2 2017. 282 funds tracked by Wall St. Rank hold EXAS as of Q3 2017.

  • Alambic Investment Management reported no remaining Exact Sciences position as of Q3 2017 after selling out during the quarter.
  • Alambic Investment Management sold 8,950 Exact Sciences shares in Q3 2017, an estimated $317K.
  • Alambic Investment Management first reported a position in Exact Sciences in Q2 2017 and held it in 1 quarter.
  • Alambic Investment Management's Exact Sciences position peaked at $317K in Q2 2017.
  • 282 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2017.

Based on Alambic Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.